Please login to the form below

Not currently logged in
Email:
Password:

rolapitant

This page shows the latest rolapitant news and features for those working in and with pharma, biotech and healthcare.

Tesaro joins PARP parade with US approval of Zejula

Tesaro joins PARP parade with US approval of Zejula

The approval comes at a buoyant time for Tesaro, which is still rolling out its first commercial product in the US - the chemotherapy-induced nausea and vomiting drug Varubi (rolapitant) - and

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics